Literature DB >> 26900761

Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS).

Jonathan B Baell1.   

Abstract

We have previously reported on classes of compounds that can interfere with bioassays via a number of different mechanisms and termed such compounds Pan Assay INterference compoundS, or PAINS. These compounds were defined on the basis of high-throughput data derived from vendor-supplied synthetics. The question therefore arises whether the concept of PAINS is relevant to compounds of natural origin. Here, it is shown that this is indeed the case, but that the context of the biological readout is an important factor that must be brought into consideration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26900761     DOI: 10.1021/acs.jnatprod.5b00947

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  95 in total

1.  Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.

Authors:  Travis R Helgren; Congling Chen; Phumvadee Wangtrakuldee; Thomas E Edwards; Bart L Staker; Jan Abendroth; Banumathi Sankaran; Nicole A Housley; Peter J Myler; Jonathon P Audia; James R Horn; Timothy J Hagen
Journal:  Bioorg Med Chem       Date:  2016-11-10       Impact factor: 3.641

2.  Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.

Authors:  Paul A Lapchak; Jacqueline M Lara; Paul D Boitano
Journal:  Transl Stroke Res       Date:  2017-04-12       Impact factor: 6.829

Review 3.  Cellular analysis of the action of epigenetic drugs and probes.

Authors:  Mirjam Hau; Fides Zenk; A Ganesan; Nicola Iovino; Manfred Jung
Journal:  Epigenetics       Date:  2017-01-10       Impact factor: 4.528

4.  The Ecstasy and Agony of Assay Interference Compounds.

Authors:  Courtney Aldrich; Carolyn Bertozzi; Gunda I Georg; Laura Kiessling; Craig Lindsley; Dennis Liotta; Kenneth M Merz; Alanna Schepartz; Shaomeng Wang
Journal:  ACS Med Chem Lett       Date:  2017-02-28       Impact factor: 4.345

5.  Internal Structure and Preferential Protein Binding of Colloidal Aggregates.

Authors:  Da Duan; Hayarpi Torosyan; Daniel Elnatan; Christopher K McLaughlin; Jennifer Logie; Molly S Shoichet; David A Agard; Brian K Shoichet
Journal:  ACS Chem Biol       Date:  2016-12-16       Impact factor: 5.100

Review 6.  Non-kinase targets of protein kinase inhibitors.

Authors:  Lenka Munoz
Journal:  Nat Rev Drug Discov       Date:  2017-03-10       Impact factor: 84.694

Review 7.  Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.

Authors:  Lindsay K Caesar; Nadja B Cech
Journal:  Nat Prod Rep       Date:  2019-06-19       Impact factor: 13.423

8.  A Realistic View on "The Essential Medicinal Chemistry of Curcumin".

Authors:  Fatemeh Bahadori; Mutlu Demiray
Journal:  ACS Med Chem Lett       Date:  2017-09-14       Impact factor: 4.345

9.  A high-throughput screening campaign to identify inhibitors of DXP reductoisomerase (IspC) and MEP cytidylyltransferase (IspD).

Authors:  Amanda Haymond; Tyrone Dowdy; Chinchu Johny; Claire Johnson; Haley Ball; Allyson Dailey; Brandon Schweibenz; Karen Villarroel; Richard Young; Clark J Mantooth; Trishal Patel; Jessica Bases; Cynthia S Dowd; Robin D Couch
Journal:  Anal Biochem       Date:  2017-11-24       Impact factor: 3.365

10.  Chemoinformatics: a perspective from an academic setting in Latin America.

Authors:  J Jesús Naveja; C Iluhí Oviedo-Osornio; Nicole N Trujillo-Minero; José L Medina-Franco
Journal:  Mol Divers       Date:  2017-12-04       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.